Pfizer Inc. (JOBS) to Shutter Six Out of 20 R&D Sites

Published: Nov 12, 2009

MarketWatch -- Pfizer Inc. said Monday it will "significantly" reduce research and development at some of its sites and shut down six out its 20 sites. Pfizer said it will shut down its R&D operations at Princeton, N.J.; Chazy, Rouses Point and Plattsburgh, N.Y.; Sanford and Research Triangle Park, N.C.; and at Gosport, Slough/Taplow in the United Kingdom. The company will also move a number of functions from Collegeville, Pa.; Pearl River, N.Y.; and St. Louis to other locations. Pfizer said the moves will result in staff reductions, but it did not specify how many.

Back to news